Traders should view this coordinated selling by the CEO and CFO as a negative signal, especially given the magnitude exceeds 0.5% of market cap. Monitor for upcoming earnings, potential downgrades, or lack of catalysts. Consider hedging long positions or reducing exposure ahead of potential downward pressure.
Price Chart
Executive Summary
Three corporate insiders at Whitehawk Therapeutics, including the CEO and CFO, sold shares in a coordinated 7-day window, generating $683,000 in total proceeds. The CFO and another insider (Ball) executed multiple open-market sales, with the CFO alone selling $592,028 worth of stock. This represents a material insider selling cluster that includes top executive leadership.
Key Financial Metrics
Key Facts
- CHIEF FINANCIAL OFFICER Scott Giacobello sold 218,600 shares across two trades (April 15 and 16) for $882,028 total (cross-filing context adds $584,808 on April 16 not in cluster document)
- CEO David James Lennon sold 14,500 shares for $49,000 on April 9
- Bryan Ball sold 118,849 shares across two trades (April 13 and 14) for $427,860 total
- Total open-market sales by insiders in 7 days: ~$1.34 million (cross-filing + cluster data)
- Total value of cluster relative to $200M market cap: ~0.67% — significant threshold exceeded
Financial Impact
$1.34 million in insider sales over 7 days (0.67% of $200M market cap)
Risk Factors
- Loss of confidence in near-term prospects due to top-executive selling
- Potential for follow-on selling by other insiders or institutions
- Possible upcoming dilutive financing or weak clinical trial results not yet disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-WHWK-1776459235874 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | 8-K | $4.11 $4.07 | ▼ −0.97% | ▼ −0.53% | $3.14 (−23.60%) |
Aug 6, 2026 11w ago | 8-K | $4.70 $4.76 | ▲ +1.28% | ▲ +0.67% | $3.14 (−33.19%) |
Jun 10, 2026 19w ago | EFFECT | $4.02 $4.06 | ▼ −0.99% | ▲ +0.70% | $3.14 (+21.89%) |
May 29, 2026 21w ago | S-3 | $4.49 $4.18 | ▲ +6.90% | ▲ +7.06% | $3.14 (+30.07%) |
May 13, 2026 23w ago | 8-K | $4.93 $5.10 | ▼ −3.45% | ▼ −2.67% | $3.14 (+36.31%) |
May 7, 2026 24w ago | 8-K | $3.94 $3.97 | ▲ +0.76% | ▼ −0.07% | $3.14 (−20.30%) |
Apr 8, 2026 28w ago | Insider Cluster | $3.55 $3.39 | ▲ +4.51% | ▲ +4.45% | $3.14 (+11.55%) |
Apr 8, 2026 28w ago | Insider Cluster | $3.55 $3.39 | ▲ +4.51% | ▲ +4.45% | $3.14 (+11.55%) |
Apr 8, 2026 28w ago | Insider Cluster | $3.55 $3.39 | ▲ +4.51% | ▲ +4.45% | $3.14 (+11.55%) |
Mar 12, 2026 32w ago | 8-K | $3.90 $3.91 | ▲ +0.26% | ▲ +0.85% | $3.14 (−19.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers